DUBLIN, March 31, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a fireside chat at the Jones Healthcare and Technology Innovation Conference in Las Vegas on ...

Wedbush initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $35 price target Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed ...

B. Riley initiated coverage of ArriVent Biopharma (AVBP) with a Buy rating and $37 price target The firm sees potential market expansion of the company’s “partially de-risked” treatment for ...

Study 0169 enrolled patients with symptomatic nOH, as defined by a 4-point or greater score on a patient reported assessment (OHSA 2 scale). Pharmacokinetic and pharmacodynamic measures were taken ...

Biotech firm Quantum BioPharma said on March 20 that it had now spent $3.5 million in total to buy BTC and other cryptocurrencies after an initial $1 million investment in December. Medical ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

Sutro Biopharma is cutting 65 jobs across two Bay Area locations. The layoffs, which are permanent according to state filings, will see three people lose their jobs at Sutro’s South San ...

Study 0169 enrolled patients with symptomatic nOH, as defined by a 4-point or greater score on a patient reported assessment (OHSA 2 scale). Pharmacokinetic and pharmacodynamic measures were taken at ...

Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Mr. Ben-Asher continued: "Having ...

Catherine Gregor, chief clinical trial officer at Florence Healthcare, said that the layoffs could jeopardize the United States’ leading position in biopharma on the global stage. “Our ...

On Tuesday, Bernstein released a report detailing the complexities of tariff risks within the biopharma sector and its potential impact on major companies. The analysis aims to unravel the ...